Balloon- vs Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses
JACC: Cardiovascular Interventions · 2023-12 · 16 (24) · 2999-3012
DOI: 10.1016/j.jcin.2023.10.028 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2023-12. Verfasst von Jorge Nuche und 17 weiteren Autor:innen. Beteiligte Einrichtung: Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Bioprosthesis, Heart Valve Prosthesis, Transcatheter Aortic Valve Replacement. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Data comparing valve systems in the valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) field have been obtained from retrospective studies. OBJECTIVES: The authors sought to compare the 1-year hemodynamic performance and clinical outcomes between balloon-expandable valves (BEV) SAPIEN 3/ULTRA (Edwards Lifesciences) and self-expanding valves (SEV) Evolut R/PRO/PRO+ (Medtronic) in ViV-TAVR. METHODS: Patients with a failed small (≤23 mm) surgical valve undergoing ViV-TAVR were randomized to receive a SEV or a BEV. Patients had a clinical and valve hemodynamic (Doppler echocardiography) evaluation at 1-year follow-up. Study outcomes were defined according to VARC-2/VARC-3 criteria. Intended performance of the valve was defined as mean gradient II, BEV: 7.3%, SEV: 4.1%; P = 0.505) or quality of life (Kansas City Cardiomyopathy Questionnaire, BEV: 77.9 ± 21.2, SEV: 81.8 ± 14.8; P = 0.334). No differences in all-cause mortality (BEV: 6.5%, SEV: 3.8; P = 0.495), heart failure hospitalization (BEV: 6.5%, SEV: 1.9%; P = 0.214), stroke (BEV: 0%, SEV: 1.9%; P = 0.369), myocardial infarction (BEV: 0%, SEV: 1.9%; P = 0.347), or pacemaker implantation (BEV: 2.2%, SEV: 1.9%; P = 0.898) were found. CONCLUSIONS: In patients who underwent ViV-TAVR for failed small aortic bioprostheses, those receiving a SEV exhibited a better valve hemodynamic profile at 1-year follow-up. There were no differences between SEV and BEV regarding functional status, quality of life, or clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
- Corewell Health East, William Beaumont University Hospital, Royal Oak, Michigan, USA.
- Hospital Universitari Vall d'Hebron, Barcelona, Spain.
- Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
- Cardiovascular Institute, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.
- Clinic Cardiovascular Institute, Hospital Clinic de Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.
Zitieren
APA
Nuche, J., Abbas, A. E., Serra, V., Vilalta, V., Nombela-Franco, L., Regueiro, A., Al-Azizi, K. M., Iskander, A., Conradi, L., Forcillo, J., Lilly, S., Calabuig, A., Fernandez-Nofrerias, E., Mohammadi, S., Giuliani, C., Pelletier-Beaumont, E., Pibarot, P., & Rodés-Cabau, J. (2023). Balloon- vs Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses. JACC: Cardiovascular Interventions, 16(24), 2999-3012. https://doi.org/10.1016/j.jcin.2023.10.028
Vancouver
Nuche J, Abbas AE, Serra V, Vilalta V, Nombela-Franco L, Regueiro A, et al. Balloon- vs Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses. JACC: Cardiovascular Interventions. 2023;16(24):2999-3012. doi:10.1016/j.jcin.2023.10.028
BibTeX
@article{Nuche2023,
author = {Nuche, Jorge and Abbas, Amr E and Serra, Vicenç and Vilalta, Victoria and Nombela-Franco, Luis and Regueiro, Ander and Al-Azizi, Karim M and Iskander, Ayman and Conradi, Lenard and Forcillo, Jessica and Lilly, Scott and Calabuig, Alvaro and Fernandez-Nofrerias, Eduard and Mohammadi, Siamak and Giuliani, Carlos and Pelletier-Beaumont, Emilie and Pibarot, Philippe and Rodés-Cabau, Josep},
title = {Balloon- vs Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses},
journal = {JACC: Cardiovascular Interventions},
year = {2023},
volume = {16},
number = {24},
pages = {2999--3012},
doi = {10.1016/j.jcin.2023.10.028}
}
EUVIMED